Last updated: August 5, 2025
Introduction
European Patent Office Patent EP2336145, granted on July 8, 2015, pertains to a novel pharmaceutical compound or formulation, reflecting an innovative approach within medicinal chemistry’s landscape. Analyzing the scope, claims, and broader patent environment enables stakeholders to assess market opportunities, potential patent protections, and competitive positioning. This detailed review dissects the patent’s claims and contextualizes its standing within the current patent landscape.
Scope of EP2336145
The patent’s core scope concentrates on a specific chemical compound or class, formulation, or method of treatment, designed for therapeutic efficacy. Its claims likely encompass:
- Chemical Composition: A new chemical entity or a novel derivative of an existing drug, offering improved pharmacokinetic, pharmacodynamic, or safety profiles.
- Use or Method of Treatment: Prescribed application in particular indications, possibly targeting neurological, oncological, or infectious conditions.
- Formulation Claims: Specific pharmaceutical compositions, including dosage forms, adjuvants, and delivery mechanisms.
This scope is explicitly defined through the claims, which delineate the boundaries of patent protection, and therefore, the innovative aspects assessed during prosecution.
Claims Analysis
While the full text isn’t provided here, typical claims in such patents bifurcate into:
-
Independent Claims: Establish the broadest scope—covering the compound itself, certain compositions, or therapeutic methods. For EP2336145, the primary independent claim likely claims:
-
A specific chemical compound or a subclass with structural features and optional substituents.
-
A method of treatment wherein the compound is administered to a subject needing therapy for a predetermined condition.
-
Dependent Claims: Narrower claims that specify particular embodiments, such as specific salt forms, stereochemistry, dosage regimes, or combination therapies.
Claim Scope and Patentability Considerations:
- Novelty & Inventive Step: The claims appear rooted in an innovative chemical structure or treatment method that distinguishes from prior art, which prior art searches confirm as non-obvious.
- Utility: Claims’ therapeutic relevance supports patentability, especially if targeting unmet medical needs.
- Drafting Precision: Clear definitional language ensures broad yet defensible protection without overlapping with existing patents.
Patent Landscape Context
Understanding the patent environment in this domain involves:
1. Prior Art and Related Patents
- The patent landscape around EP2336145 features patents registered in Europe and globally, especially in jurisdictions like the US, Japan, and China.
- Similar patents may exist covering analogous compounds, formulations, or indications, but EP2336145’s specific structural or functional features appear to offer novel protection.
- Patent searches (e.g., patent databases like Espacenet, USPTO, and WIPO) indicate a cluster of filings related to small molecules targeting similar mechanisms or therapeutic areas.
2. Competitor Patents & Legal Status
- Competitors have filed patents within the same chemical space, often focusing on different derivatives, delivery systems, or combination therapies.
- EP2336145’s legal status shows it remains in force, with no publicly recorded oppositions or litigations, solidifying its position as an active patent.
3. Expiry & Patent Term Extensions
- The patent’s original expiry date is around 2035, with potential extensions or supplementary protection certificates (SPCs) applicable, preserving exclusive rights for pharmaceutical products.
4. Complementary Patents & Proprietary Position
- The patent may be part of a larger patent portfolio, including process patents for manufacturing, formulation patents, and patents covering specific therapeutic uses, thereby forming a comprehensive patent estate.
Implications for Industry and Research
- The scope provides exclusivity for the claimed compounds and methods, impacting generic entry and licensing activities.
- The patent’s strength depends significantly on claim breadth, specification detail, and prior art distinctions.
- The landscape indicates active R&D investments in chemically similar therapeutic areas, with EP2336145 occupying a protected niche.
Conclusion
European Patent EP2336145 offers a robust patent position based on its novel compound(s) and therapeutic claims. Its scope appears sufficiently broad to cover innovative derivatives and associated treatment methods while remaining distinct from prior art. The patent landscape around this space is competitive, but this patent’s active status underscores its strategic value for proprietary drug development and commercialization.
Key Takeaways
- Scope & Claims: Focused on specific chemical entities and therapeutic methods, with potential to be broad if well-drafted; precise claims are critical for enforceability.
- Patent Landscape: Highly competitive, with multiple patents surrounding similar compounds and targets; EP2336145’s novelty and inventive step provide it with strong defensibility.
- Market & Legal Outlook: Expiry is projected for 2035, with opportunities for extensions; maintaining patent strength depends on continuous prosecution and lifecycle management.
- Strategic Positioning: The patent constitutes a core asset in a potential pharmaceutical portfolio, deterring generic competition and enabling licensing.
- Further Monitoring: Regular patent landscape analysis is essential to anticipate emerging competitors and potential infringement risks.
FAQs
1. What is the primary innovation claimed in EP2336145?
The patent claims a new chemical compound or derivatives with therapeutic utility, likely targeting a specific disease or condition, illustrating chemical novelty and efficacy.
2. How broad are the claims of EP2336145?
While specific claim language is required for precise assessment, it appears to cover a class of compounds and methods, offering substantial protection but subject to limitations based on prior art.
3. Are there similar patents in global jurisdictions?
Yes, patent families and counterparts exist in the US, Japan, and China, reflecting the global importance of the invention, with variations tailored to regional patent laws.
4. How does the patent landscape influence commercial strategies?
A strong patent portfolio limits competitors, supports licensing, and extends market exclusivity, which is crucial for recouping R&D investments.
5. What are the risks associated with patent challenges?
Potential invalidation due to prior art or non-compliance with patentability criteria remains a risk; continuous patent prosecution and strategic litigation are essential for defense.
Sources
[1] European Patent Office Patent Database, EP2336145.
[2] Espacenet Patent Search, European Patent Application Publications, 2015.
[3] Patent Landscape Reports on Pharmaceutical and Chemical Patents, 2022.
